Cooperative Influence of the Interleukin-6 Promoter Polymorphisms -597, -572 and -174 on Long-Term Kidney Allograft Survival

American Journal of Transplantation

Volumn 4, Issue 3, 2004, Pages 402-406

  Müller Steinhardt, Michael ^a   Fricke, Lutz ^a   Müller, Brigitte ^b   Ebel, Brigitte ^a   Kirchner, Holger ^a   Härtel, Christoph ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

597 572 174 haplotype; Interleukin 6; Kidney allograft survival; Promoter polymorphism

Indexed keywords

ADENINE; AZATHIOPRINE; CYCLOSPORIN A; CYTOSINE; GUANINE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 6; METHYLPREDNISOLONE;

ARTICLE; CADAVER; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FUNCTION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENOTYPE; GRAFT SURVIVAL; HAPLOTYPE; HEREDITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION;

GRAFT SURVIVAL; HUMANS; INTERLEUKIN-6; KIDNEY TRANSPLANTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS);

EID: 1442338549     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00356.x     Document Type: Article

References (18)

1. Opelz G, Mytilineos J, Scherer S, Schwarz V. Clinical implications of DNA typing in organ transplantation. The Collaborative Transplant Study. Transplant Proc 1997; 29: 1524-1527.
2. Asderakis A, Sankaran D, Dyer P et al. Association of polymorphisms in the human interferon-gamma and interleukin-10 gene with acute and chronic kidney transplant outcome: the cytokine effect on transplantation. Transplantation 2001; 71: 674-677.
3. Hahn AB, Kasten-Jolly JC, Constantino D et al. TNF-alpha, IL-6, IFN-gamma, and IL-10 gene expression polymorphisms and the IL-4 receptor alpha-chain variant Q576R: effects on renal allograft outcome. Transplantation 2001; 72: 660-665.
4. Marshall SE, McLaren AJ, McKinney EF et al. Donor cytokine genotype influences the development of acute rejection after renal transplantation. Transplantation 2001; 71: 469-476.
5. Müller-Steinhardt M, Härtel C, Müller B, Kirchner H, Fricke L. The interleukin-6-174promoter polymorphism is associated with long-term kidney allograft survival. Kidney Int 2002; 62: 1824-1827.
6. Fishman D, Faulds G, Jeffery R et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-1376.
7. Tilg H, Dinarello CA, Mier JW. IL-6 and APPs anti-inflammatory and immunosuppressive mediators. Immunol Today 1997; 18: 428-432.
8. Xing Z, Gauldie J, Cox G et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998; 101: 311-320.
9. La Flamme AC, Pearce EJ. The absence of IL-6 does not affect Th2 cell development in vivo, but does lead to impaired proliferation, IL-2 receptor expression, and B cell responses. J Immunol 1999; 162: 5829-5837.
10. Rincon M, Anguita J, Nakamura T, Fikrig E, Flavell RA. Interleukin (IL) -6 directs the differentiation of IL-4-producing CD4+ T cells. J Exp Med 1997; 185: 461-469.
11. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000; 275: 18138-18144.
12. Jordanides N, Eskdale J, Stuart R, Gallagher G. Allele associations reveal four prominent haplotypes atthe human interleukin-6 (IL-6) locus. Genes Immunol 2000; 1: 451-455.
13. Villuendas G, San Millan JL, Sancho J, Escobar-Morreale HF. The -597 G/A and -174 G/C polymorphisms in the promoter of the IL-6 gene are associated with hyperandrogenism. J Clin Endocrinol Metab 2002; 87: 1134-1141.
14. Morton NE, Zhang W, Taillon-Miller P, Ennis S, Kwok PY, Collins A. The optimal measure of allelic association. Proc Natl Acad Sci U S A 2001; 98: 5217-5221.
15. Ray A, LaForge KS, Sehgal PB. On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids, enhancer, TATA box, and RNA start site (Inr motif) occlusion. Mol Cell Biol 1990; 10: 5736-5746.
16. Cavet J, Dickinson AM, Norden J, Taylor PR, Jackson GH, Middleton PG. Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood 2001; 98: 1594-1600.
17. Jones KG, Brull DJ, Brown LC et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 2001; 103: 2260-2265.
18. Georges JL, Loukaci V, Poirier O et al. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Temoin de l'Infarctus du Myocarde. J Mol Med 2001; 79: 300-305.